---
layout: page
excerpt: "Publications"
---

Graff, J.N., Alumkal, J.J., Thomas, G.V. Thompson, R.F., Moran, A.E., **Wood, M.A.**, Drake, C.G., Slottke, R.E., Beer, T.M. (2020). [A Phase II, Single-Arm Study of Pembrolizumab with Enzalutamide in Men with Metastatic Castration Resistant Prostate Cancer Progressing on Enzalutamide Alone.](https://jitc.bmj.com/content/8/2/e000642) _Journal for ImmunoTherapy of Cancer_. 8:e000642.

Nguyen, A., David, J.K., Maden S.K., **Wood M.A.**, Weeder, B.R., Nellore, A., Thompson, R.F. (2020). [Human leukocyte antigen susceptibility map for SARS-CoV-2.](https://jvi.asm.org/content/94/13/e00510-20) _Journal of Virology_. JVI.00510-20.

**Wood, M.A.**, Weeder, B.R., David, J.K., Nellore, A., Thompson, R.F. (2020). [Burden of tumor mutations, neoepitopes, and other variants are weak predictors of cancer immunotherapy response and overall survival.](https://genomemedicine.biomedcentral.com/articles/10.1186/s13073-020-00729-2) _Genome Medicine_, _12_, 33.

**Wood, M.A.**, Nguyen, A., Struck, A.J., Ellrott, K., Nellore, A., Thompson, R.F. (2020). [`neoepiscope` improves neoepitope prediction with multi-variant phasing.](https://academic.oup.com/bioinformatics/article/36/3/713/5551338) _Bioinformatics_, _36(3)_, 713-720. 

**Wood, M.A.**, Nellore, A., Thompson, R.F. (2019). [Tumor Mutation Burden â€“ From Doubts to Concerns.](https://jamanetwork.com/journals/jamaoncology/fullarticle/2753173) _JAMA Oncology_, _5(12)_, 1808-1809.

**Wood, M.A.**, Paralkar, M., Paralkar, M.P., Nguyen, A., Struck, A.J., Ellrott, K., Margolin, M., Nellore, A., Thompson, R.F. (2018). [Population-level distribution and putative immunogenicity of cancer neoepitopes.](https://bmccancer.biomedcentral.com/articles/10.1186/s12885-018-4325-6) _BMC Cancer_, _18_, 414. 
